Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lymphatic Metastasis × Gynecologic × Clear all

Phase

Status

Recruiting 7 Unknown 5 Completed 4 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1

Conditions

Ovarian Neoplasms 95 Uterine Cervical Neoplasms 51 Endometrial Neoplasms 32 Fallopian Tube Neoplasms 29 Carcinoma, Ovarian Epithelial 26 Breast Neoplasms 22 Neoplasms 13 Pancreatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Uterine Cervical Dysplasia 11 Recurrence 10 Stomach Neoplasms 9 Colorectal Neoplasms 9 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 7 Sarcoma 7 Urinary Bladder Neoplasms 6 Lung Neoplasms 6 Vulvar Neoplasms 5 Vaginal Neoplasms 5 Testicular Neoplasms 5 Esophageal Neoplasms 5 Uterine Neoplasms 4 Rectal Neoplasms 4 Peritoneal Neoplasms 4 Melanoma 4 Lymphoma, Non-Hodgkin 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Sezary Syndrome 3

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05504642 2023-04-18

CERAD-IMMUNE

Universitätsklinikum Köln

Phase 2 Withdrawn

Uterine Cervical Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡